 |
|
[Alpha Biz=(Chicago) Reporter Kim Jisun] SK Bioscience has joined hands with the Serbian government for vaccine development and production cooperation. It plans to build a vaccine production base in Serbia to make it a stepping stone to enter the European market.
SK Bioscience announced on August 8 that Serbian Prime Minister Ana Brnabić visited the headquarters in Pangyo, Gyeonggi-do, and signed a memorandum of understanding (MOU). SK Bioscience is the only domestic pharmaceutical and bio company visited by Prime Minister Brenavic, who visited Korea for the first time in 13 years since 2010.
The Serbian government, SK Bioscience and Frontier Biopharma will sign a detailed contract by the end of this year based on MOU and start establishing and commercializing vaccine production facilities in Serbia.
The Serbian government, along with administrative support for the project, cooperates to ensure that finished products are quickly procured in Serbia. Frontier Biopharma will take charge of the overall operation of the project.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
